Emergent Biosolutions (EBS) Issues Q3 Miss
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.05 -1.59%
Revenue Growth %: +32.0%
Financial Fact:
Product sales: 96.7M
Today's EPS Names:
CCEL, FEIM, PLG, More
Revenue Growth %: +32.0%
Financial Fact:
Product sales: 96.7M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Emergent Biosolutions (NYSE: EBS) reported Q3 EPS of $0.04, $0.06 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $58.8 million versus the consensus estimate of $63.59 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
- PepsiCo (PEP) Misses Q2 EPS by 1c, Beats on Revenue
- AZZ, Inc. (AZZ) Tops Q1 EPS by 16c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
